• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恰加斯病:流行病学、诊断与治疗。

Chagas Disease: Epidemiology, Diagnosis, and Treatment.

机构信息

Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, USA.

Pulmonary Division, Heart Institute (InCor), University of Sao Paulo, Sao Paulo, SP, Brazil.

出版信息

Curr Cardiol Rep. 2024 Oct;26(10):1105-1112. doi: 10.1007/s11886-024-02113-7. Epub 2024 Aug 8.

DOI:10.1007/s11886-024-02113-7
PMID:39115799
Abstract

PURPOSE OF REVIEW

This review seeks to describe the updates in the literature - particularly with regards to the epidemiology and diagnosis of Chagas disease. Additionally, this paper describes updates to the antiparasitic treatment for Chagas disease.

RECENT FINDINGS

With regards to changing epidemiology, autochthonous cases are being found within the USA in addition to Latin America. Additionally, there appears to be more intermixing of discrete typing units-meaning, they are not confined to specific geographic regions. Screening for Chagas disease is recommended in persons who lived in areas with endemic Chagas, persons wtih family member diagnosed with Chagas Disease, persons who have lived in homes of natural material in Latin America, and persons with history of kissing bug bites. Treatment for the parasitic infection remains limited to benznidazole and nifurtimox, and the role of these treatments in Chagas cardiomyopathy has not yet been definitively defined. Finally, indications for and management of heart transplant in the setting of Chagas disease are discussed.

FUTURE RESEARCH

Use of antiparasitics during chronic chagas disease should be further explored. Additionally, future research identifying other markers of infection would be valuable to defining cure from infection.

摘要

目的综述

本篇综述旨在描述有关克氏锥虫病的文献更新,特别是流行病学和诊断方面的更新。此外,本文还介绍了克氏锥虫病驱虫治疗的更新。

最近的发现

在拉丁美洲以外的美国,也发现了土生土长的病例。此外,离散型单元似乎有更多的混合,这意味着它们不再局限于特定的地理区域。建议对以下人群进行克氏锥虫病筛查:居住在克氏锥虫病流行地区的人、有确诊克氏锥虫病家族成员的人、居住在拉丁美洲天然材料房屋中的人、有接吻虫叮咬史的人。寄生虫感染的治疗仍然局限于苯并咪唑和硝呋莫司,这些治疗方法在克氏锥虫心肌病中的作用尚未明确界定。最后,讨论了克氏锥虫病患者心脏移植的适应证和处理。

未来研究

应进一步探索慢性克氏锥虫病期间使用驱虫药物的情况。此外,发现其他感染标志物的未来研究对于确定从感染中治愈将是有价值的。

相似文献

1
Chagas Disease: Epidemiology, Diagnosis, and Treatment.恰加斯病:流行病学、诊断与治疗。
Curr Cardiol Rep. 2024 Oct;26(10):1105-1112. doi: 10.1007/s11886-024-02113-7. Epub 2024 Aug 8.
2
[What is not searched, it is difficult to find: Chagas' disease].不探寻,便难以发现:恰加斯病
G Ital Cardiol (Rome). 2016 May;17(5):343-7. doi: 10.1714/2252.24258.
3
Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).用于晚期有症状的恰加斯病(克氏锥虫感染)的杀锥虫药物。
Cochrane Database Syst Rev. 2020 Dec 11;12(12):CD004102. doi: 10.1002/14651858.CD004102.pub3.
4
Recognition for Chagas disease.恰加斯病的认知。
Lancet Infect Dis. 2019 Jul;19(7):699. doi: 10.1016/S1473-3099(19)30319-6.
5
Recognizing and meeting the challenge of Chagas disease in the USA.认识并应对美国的恰加斯病挑战。
Expert Rev Anti Infect Ther. 2009 Dec;7(10):1223-34. doi: 10.1586/eri.09.107.
6
Antitrypanosomal therapy for chronic Chagas' disease.慢性恰加斯病的抗锥虫治疗。
N Engl J Med. 2011 Jun 30;364(26):2527-34. doi: 10.1056/NEJMct1014204.
7
Perspectives in Chagas disease treatment.恰加斯病治疗的展望。
Glob Heart. 2015 Sep;10(3):189-92. doi: 10.1016/j.gheart.2015.07.007.
8
Diagnosis and Management of Chagas Cardiomyopathy in the United States.美国的恰加斯心肌病的诊断与管理。
Curr Cardiol Rep. 2018 Oct 11;20(12):131. doi: 10.1007/s11886-018-1077-5.
9
Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America.在拉丁美洲,提高对恰加斯病患者的诊断和治疗机会的策略。
Expert Rev Anti Infect Ther. 2019 Mar;17(3):145-157. doi: 10.1080/14787210.2019.1577731. Epub 2019 Feb 13.
10
Current status of Chagas disease chemotherapy.恰加斯病化疗的现状。
Expert Rev Anti Infect Ther. 2011 May;9(5):609-20. doi: 10.1586/eri.11.31.

引用本文的文献

1
Palladium-Catalyzed C-H Arylation of Quinoidal Scaffolds Through Homogeneous and Heterogeneous Pathways: Advancing Toward Trypanocidal Prototypes.通过均相和非均相途径实现的钯催化醌类骨架的C-H芳基化:迈向抗锥虫原型
ACS Omega. 2025 Aug 14;10(33):37898-37905. doi: 10.1021/acsomega.5c05006. eCollection 2025 Aug 26.
2
Antiparasitic Effect of Polyphenols and Terpenes from Natural Products Against and .天然产物中的多酚和萜类化合物对[寄生虫名称]和[寄生虫名称]的抗寄生虫作用 。 注:原文中“and”前后的寄生虫名称缺失,翻译时用[寄生虫名称]表示。
Metabolites. 2025 Aug 21;15(8):560. doi: 10.3390/metabo15080560.
3
The Role of Hematophagous Arthropods, Other than Mosquitoes and Ticks, in Arbovirus Transmission.

本文引用的文献

1
Clinical trials for Chagas disease: etiological and pathophysiological treatment.恰加斯病的临床试验:病因学和病理生理学治疗
Front Microbiol. 2023 Dec 15;14:1295017. doi: 10.3389/fmicb.2023.1295017. eCollection 2023.
2
Chagas disease.恰加斯病
Lancet. 2024 Jan 13;403(10422):203-218. doi: 10.1016/S0140-6736(23)01787-7. Epub 2023 Dec 7.
3
SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023.巴西心脏病学会2023年恰加斯病心肌病患者诊断与治疗指南
除蚊子和蜱虫外的吸血节肢动物在虫媒病毒传播中的作用
Viruses. 2025 Jun 30;17(7):932. doi: 10.3390/v17070932.
4
Trypanosoma cruzi: A new system for primary culture and isolation of the parasite.克氏锥虫:一种用于该寄生虫原代培养和分离的新系统。
Parasitol Res. 2025 Jul 16;124(7):83. doi: 10.1007/s00436-025-08511-2.
5
One Strain Many Compounds Approach for Anti- Compounds: Empowering the Marine Bacterium .抗化合物的“一种菌株多种化合物”方法:增强海洋细菌的能力
ACS Omega. 2025 May 1;10(18):18444-18456. doi: 10.1021/acsomega.4c10784. eCollection 2025 May 13.
6
Heart transplantation in South America: Risk factors, challenges, and opportunities.南美洲的心脏移植:风险因素、挑战与机遇。
JHLT Open. 2024 Nov 28;7:100186. doi: 10.1016/j.jhlto.2024.100186. eCollection 2025 Feb.
7
Transmission Through Blood Samples and Derivatives: Main Routes, Control Strategies, and Recent Advancements in Blood Banks.通过血液样本及其衍生物的传播:主要途径、控制策略及血库的最新进展
Pathogens. 2025 Feb 2;14(2):133. doi: 10.3390/pathogens14020133.
8
Exploring Marine Natural Compounds: Innovative Therapeutic Candidates Against Chagas Disease Through Virtual Screening and Molecular Dynamics.探索海洋天然化合物:通过虚拟筛选和分子动力学寻找治疗恰加斯病的创新候选药物。
Life (Basel). 2025 Jan 28;15(2):192. doi: 10.3390/life15020192.
9
Development and Characterization of Innovative Nifurtimox Formulations as Therapeutic Alternative for Chagas Disease.创新硝呋替莫制剂的开发与特性研究作为恰加斯病的治疗替代方案
Trop Med Infect Dis. 2025 Feb 7;10(2):50. doi: 10.3390/tropicalmed10020050.
Arq Bras Cardiol. 2023 Jun 26;120(6):e20230269. doi: 10.36660/abc.20230269.
4
Evidence of likely autochthonous Chagas disease in the southwestern United States: A case series of Trypanosoma cruzi seropositive blood donors.可能源自美国西南部的恰加斯病证据:一组克氏锥虫血清阳性献血者的病例系列。
Transfusion. 2022 Sep;62(9):1808-1817. doi: 10.1111/trf.17026. Epub 2022 Jul 27.
5
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas.克氏锥虫的离散型:在美洲的地理和生物学分布。
Sci Data. 2022 Jun 24;9(1):360. doi: 10.1038/s41597-022-01452-w.
6
Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States.美国成年人中查加斯病流行率的更新估计和绘图。
Emerg Infect Dis. 2022 Jul;28(7):1313-1320. doi: 10.3201/eid2807.212221.
7
Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2001-2021.2001-2021 年美国通过疾病预防控制中心赞助的新药研究计划发放用于治疗恰加斯病的硝呋替莫的患者特征和不良事件。
MMWR Morb Mortal Wkly Rep. 2022 Mar 11;71(10):371-374. doi: 10.15585/mmwr.mm7110a2.
8
Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis.慢性恰加斯心肌病的死亡风险:系统评价和荟萃分析。
ESC Heart Fail. 2021 Dec;8(6):5466-5481. doi: 10.1002/ehf2.13648. Epub 2021 Oct 30.
9
Recommendations for Screening and Diagnosis of Chagas Disease in the United States.美国恰加斯病筛查和诊断的推荐建议。
J Infect Dis. 2022 May 4;225(9):1601-1610. doi: 10.1093/infdis/jiab513.
10
Survival after heart transplantation for Chagas cardiomyopathy using a conventional protocol: A 10-year experience in a single center.采用常规方案进行心脏移植治疗克氏心肌病的 10 年单中心经验:患者的存活率。
Transpl Infect Dis. 2021 Aug;23(4):e13549. doi: 10.1111/tid.13549. Epub 2021 Jun 1.